John K. Chan

Inherited Mutations in Women With Ovarian Carcinoma

Barbara M. Norquist, Maria I. Harrell, Mark F. Brady et al. · JAMA Oncology · 2015 · 748 citations · Full text

Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality

Sin‐Ming Chow, Stephen C.K. Law, John K. Chan et al. · Cancer · 2003 · 723 citations

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

Chad A. Hamilton, M. K. Cheung, Kathryn Osann et al. · British Journal of Cancer · 2006 · 655 citations · Full text

Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial

Robert L. Coleman, Mark F. Brady, Thomas J. Herzog et al. · The Lancet Oncology · 2017 · 585 citations · Full text

Paclitaxel–carboplatin Chemotherapy, Secondary Cytoreduction, Medicine +9

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller et al. · The Lancet Oncology · 2019 · 516 citations

Oncology, Metronomic Therapy, Gynecology +6